Metabolon To Sponsor Study At Geisinger Medical Center With Quantose IR To Monitor Prediabetes Therapy
6/24/2014 7:57:53 AM
RESEARCH TRIANGLE PARK, N.C., June 23, 2014 (GLOBE NEWSWIRE) -- Metabolon, Inc., a global leader in metabolomics, announced today that it will sponsor a pilot study to evaluate its Quantose IRTM test as a monitor of glycemic control in people with prediabetes. The study, which will monitor prediabetic subjects using Quantose IR, hemoglobin A1c and fasting plasma glucose (FPG) results over a 12-week period, will be conducted by the Cardiovascular Center for Clinical Research at Geisinger Medical Center in Danville, PA. Study participants will be on a regimen of metformin, diet and exercise.
Help employers find you! Check out all the jobs and post your resume
comments powered by